One year ago, Congress defunded public media. Now that we're 100% community funded, please become a sustaining member or increase your existing membership today.
An RSV Vaccine For Babies Could Be Coming Soon
A vaccine syringe sits on a table.
(
Mario Tama
/
Getty Images
)
Topline:
A new shot could soon be available to protect babies from RSV, a highly contagious respiratory disease.
What will the shot do? It’s a monoclonal antibody that can both prevent and treat infections in infants who have already been diagnosed with RSV. Dr. Kimberly Shriner, infectious disease specialist at Huntington Hospital, told our newsroom’s AirTalk program the development is “very important,” as RSV was recently responsible for a surge in hospitalizations in the U.S. among infants and small children.
“The huge number of children that were getting RSV speaks to the importance of vigilance,” said Shriner, “and the need for developing effective therapies and preventative measures, including vaccines and antibiotic therapy.”
What’s the next step for the shot? The single dose antibody, known as Nirsevimab, still needs FDA approval. That could happen later this summer, making the drug available for babies up to 24 months old.
One year ago, Congress voted to defund public media, eliminating a critical $1.7 million from our budget every year going forward. But they couldn’t silence us, and we’re not going anywhere. LAist is now 100% community funded and that means we’re taking our future into our own hands and turning to you to keep local reporting strong.
You come to LAist because you want independent reporting and trustworthy local information. Our nonprofit newsroom doesn’t answer to shareholders looking to turn a profit. Instead, we answer to you and our communities. We are free to follow facts wherever they lead and to hold power to account without fear or favor. Our only loyalty is to our readers and listeners and our mission: to inform, engage, and strengthen Southern California’s communities.
If this story helped you, please become a monthly member today to help sustain this mission. It just takes 1 minute to donate below.
You come to LAist because you want independent reporting and trustworthy local information. Our nonprofit newsroom doesn’t answer to shareholders looking to turn a profit. Instead, we answer to you and our communities. We are free to follow facts wherever they lead and to hold power to account without fear or favor. Our only loyalty is to our readers and listeners and our mission: to inform, engage, and strengthen Southern California’s communities.
If this story helped you, please become a monthly member today to help sustain this mission. It just takes 1 minute to donate below.
Senior Vice President News, Editor in Chief
